| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/EJHF.82 |
| P698 | PubMed publication ID | 24723498 |
| P2093 | author name string | Allan Flyvbjerg | |
| Jan Frystyk | |||
| Mette Bjerre | |||
| Jan Skov Jensen | |||
| Rasmus Mogelvang | |||
| Søren Lindberg | |||
| Sune H Pedersen | |||
| P2860 | cites work | Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome | Q29619211 |
| The validity of the diagnosis of acute myocardial infarction in routine statistics: a comparison of mortality and hospital discharge data with the Danish MONICA registry | Q30779443 | ||
| Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure | Q34139611 | ||
| Atrial natriuretic peptide and adiponectin interactions in man | Q34391434 | ||
| Regulation of lipolysis: natriuretic peptides and the development of cachexia | Q34774452 | ||
| Cardiac natriuretic peptides act via p38 MAPK to induce the brown fat thermogenic program in mouse and human adipocytes | Q35780260 | ||
| Natriuretic peptides enhance the oxidative capacity of human skeletal muscle. | Q36498070 | ||
| Nitric oxide bioavailability and adiponectin production in chronic systolic heart failure: relation to severity of cardiac dysfunction | Q36951519 | ||
| Control of lipolysis by natriuretic peptides and cyclic GMP. | Q37109051 | ||
| Higher Natriuretic Peptide Levels Associate With a Favorable Adipose Tissue Distribution Profile | Q37378648 | ||
| A new role for the natriuretic peptides: metabolic regulators of the adipocyte | Q42761019 | ||
| Prognostic evaluation of neurohumoral plasma levels before and during beta-blocker therapy in advanced left ventricular dysfunction | Q43703660 | ||
| Discriminating between cardiac and pulmonary dysfunction in the general population with dyspnea by plasma pro-B-type natriuretic peptide | Q44157435 | ||
| Total and high molecular weight adiponectin, haemodynamics, and mortality in patients with chronic heart failure | Q45033818 | ||
| Plasma adiponectin is associated with plasma brain natriuretic peptide and cardiac function in healthy subjects | Q45270304 | ||
| Weight loss larger than 10% is needed for general improvement of levels of circulating adiponectin and markers of inflammation in obese subjects: a 3-year weight loss study. | Q46784156 | ||
| Natriuretic peptides enhance the production of adiponectin in human adipocytes and in patients with chronic heart failure | Q47705098 | ||
| Relation of adiponectin and high-sensitivity C-reactive protein to pulse-wave velocity and N-terminal pro-B-type natriuretic peptide in the general population | Q47847380 | ||
| High adiponectin and increased risk of cardiovascular disease and mortality in asymptomatic older men: does NT-proBNP help to explain this association? | Q48184467 | ||
| Serum adiponectin level as an independent predictor of mortality in patients with congestive heart failure | Q48189664 | ||
| Increase in serum adiponectin concentration in patients with heart failure and cachexia: relationship with leptin, other cytokines, and B-type natriuretic peptide | Q48220219 | ||
| Prognostic Value of Circulating Adipokine Levels and Expressions of Adipokines in the Myocardium of Patients With Chronic Heart Failure | Q48444541 | ||
| Gender differences of oligomers and total adiponectin during puberty: a cross-sectional study of 859 Danish school children | Q50544798 | ||
| β-blockers modify the prognostic value of adiponectin in chronic heart failure | Q51770424 | ||
| Atrial natriuretic peptide regulates lipid mobilization and oxygen consumption in human adipocytes by activating AMPK | Q54581836 | ||
| Increased serum adiponectin levels in type 1 diabetic patients with microvascular complications | Q59489258 | ||
| Adiponectin is released from the heart in patients with heart failure | Q80485692 | ||
| Increased adiponectin level in parallel with increased NT-pro BNP in patients with severe heart failure in the elderly: A hospital cohort study | Q80593880 | ||
| Effect of atrial natriuretic peptide on adiponectin in patients with heart failure | Q80916759 | ||
| Dual ACE/NEP inhibitors - more than playing the ACE card | Q82860693 | ||
| High plasma adiponectin is related to low functional capacity in patients with chronic heart failure | Q83256130 | ||
| Effect of creatinine assay standardization on the performance of Cockcroft-Gault and MDRD formula in predicting GFR | Q83876837 | ||
| Relation of Serum Adiponectin Levels to Number of Traditional Atherosclerotic Risk Factors and All-Cause Mortality and Major Adverse Cardiovascular Events (from the Copenhagen City Heart Study) | Q86044125 | ||
| P433 | issue | 6 | |
| P304 | page(s) | 633-638 | |
| P577 | publication date | 2014-04-10 | |
| P1433 | published in | European Journal of Heart Failure | Q5017954 |
| P1476 | title | Cardio-adipose tissue cross-talk: relationship between adiponectin, plasma pro brain natriuretic peptide and incident heart failure | |
| P478 | volume | 16 |
| Q92020742 | Adiponectin and the risk of new-onset atrial fibrillation: a meta-analysis of prospective cohort studies |
| Q48240054 | Baseline adiponectin concentration and clinical outcomes among patients with diabetes and recent acute coronary syndrome in the EXAMINE trial. |
| Q35885563 | Cardiomyocyte Antihypertrophic Effect of Adipose Tissue Conditioned Medium from Rats and Its Abrogation by Obesity is Mediated by the Leptin to Adiponectin Ratio |
| Q38803877 | Commentary: Heart Failure with Preserved Ejection Fraction Induces Beiging in Adipose Tissue |
| Q92537528 | Examining the Potential of Developing and Implementing Use of Adiponectin-Targeted Therapeutics for Metabolic and Cardiovascular Diseases |
| Q98174573 | High plasma adiponectin is associated with increased pulmonary blood flow and reduced right ventricular function in patients with pulmonary hypertension |
| Q34344972 | Immuno-modulator metallo-Peptide reduces inflammatory state in obese zucker fa/fa rats |
| Q34681621 | Muscle wasting and cachexia in heart failure: mechanisms and therapies |
| Q90166128 | Plasma concentration and expression of adipokines in epicardial and subcutaneous adipose tissue are associated with impaired left ventricular filling pattern |
| Q52738986 | Podocan Is Expressed in Blood and Adipose Tissue and Correlates Negatively With the Induction of Diabetic Nephropathy |
| Q36535122 | Relation of Adiponectin to All-Cause Mortality, Cardiovascular Mortality, and Major Adverse Cardiovascular Events (from the Dallas Heart Study). |
| Q89349260 | Tipping the scales toward fitness as a key modifier of the obesity paradox in heart failure |
| Q91260359 | Total adiponectin is associated with incident cardiovascular and renal events in treated hypertensive patients: subanalysis of the ATTEMPT-CVD randomized trial |
Search more.